Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like Fast-Growing Intarcia Awaits Crucial FDA Decision in New Boston HQ May 7, 2017 Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System March 9, 2017 3 Biotechs Facing Stiff Headwinds in 2018 February 13, 2018
Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System March 9, 2017
